Aptevo Therapeutics holds special shareholder meeting

• Aptevo Therapeutics held a special stockholder meeting on Sept. 22, 2026.
• Stockholders rejected an amendment to the amended and restated certificate of incorporation covering technical and administrative changes.
• Investors authorized issuing more than 20% of outstanding common stock tied to warrant reload and private placement transactions.
• Holders adopted the Fifth Amended and Restated 2018 Stock Incentive Plan.
• Shareholders also authorized adjourning the special meeting to a later date if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-399545), on September 23, 2026, and is solely responsible for the information contained therein.